Los Angeles Urological Clinical Trials at Tower Urology
At Tower Urology, our commitment to advancing urologic care goes beyond treatment—we actively participate in cutting-edge clinical trials that offer patients access to promising new therapies before they become widely available.
As a leading urological practice in California, we ensure every study is conducted with the highest standards of safety, ethics, and patient support. By joining a clinical trial at Tower Urology, you become part of a carefully guided journey toward innovation in prostate health, bladder conditions, erectile dysfunction, and more.
Our expert team will walk you through every step, empowering you to make informed decisions while contributing to medical breakthroughs that could transform lives.
Active Trials:
Bladder Cancer Study with EnGene Pharma
Location:
Los Angeles
Start Date:
Now Enrolling
Physician
Dr. Bui
Type:
High risk NMIBC
Criteria:
BCG unresponsive NMIBC who are indicated for, ineligible for or have elected not to undergo cystectomy or high-risk NMIBC Patients who are BCG naïve or received incomplete BCG treatment.
Prostate Cancer Study with Debio pharma
Location:
Los Angeles
Start Date:
Now Enrolling
Physician
Dr. Bui
Type:
Locally advanced/mPCa
Criteria:
Phase 2, randomized, open-label, dose finding study of Debio4228, an extended-release formulation of Degarelix in locally advanced/metastatic prostate cancer.
Erectile Dysfunction Study with Boston Scientific
Location:
Los Angeles
Start Date:
Now Enrolling
Physician
Dr. Houman
Type:
Registry Trial for Penile Prosthesis
Criteria:
Assess erectile function at 6 months post implantation of penile prosthesis (inflatable prosthesis and malleable prosthesis).
Prostate Cancer Study with Curium Pharma
Location:
Los Angeles
Start Date:
Now Enrolling
Physician
Dr. Josephson
Type:
Newly Diagnosed Unfavorable PCA
Criteria:
A multi-center, open-label, randomized Phase 3 study of Cu 64 PSMA I&T injection PET in staging of patients with newly diagnosed unfavorable high-risk to very high-risk cancer electing to undergo radical prostatectomy with pelvic lymph node dissection.
Hypogonadism Study with Repro Novo
Location:
Los Angeles
Start Date:
Not Enrolling
Physician
Dr. Houman
Type:
Hypogonadotropic Hypogonadism, SIV done
Criteria:
A randomized, placebo-controlled, double-blind, parallel-group, dose-response trial evaluating the efficacy and safety of leflutrozole on testicular function in men with hypogonadotropic hypogonadism.
Prostate Cancer Study with AstraZeneca
Location:
Los Angeles
Start Date:
Not Enrolling
Physician
Dr. Josephson
Type:
Localized high risk receiving radiotherapy, SIV not done
Criteria:
A randomized, double-blind, placebo-controlled, phase III study of Adjuvant Saruparib (AZD5305) in patients with BRCAm localized high-risk prostate cancer receiving radiotherapy with androgen deprivation therapy (EvoPAR-Prostate02).
Bladder Cancer Study with Aura Biosciences
Location:
Los Angeles
Start Date:
Not Enrolling
Physician
Dr. Josephson
Type:
NMIBC or MIBC, SIV done
Criteria:
A Phase 1, open-label trial of Belzupacap Sarotalocan (AU-011) to determine the feasibility and safety of Intratumoral injection with or without Intramural injection in subjects with bladder cancer.
Bladder Cancer Study with ImmVira
Location:
Los Angeles
Start Date:
Not Enrolling
Physician
Dr. Josephson
Type:
High risk NMIBC, SIV not done
Criteria:
An open-label, international, multicenter Phase II study to evaluate the efficacy and safety of Intravesical T3011 injection in participants with BCG-unresponsive high-risk non-muscle-invasive bladder cancer (NMIBC) or BCG-exposed, chemotherapy-unresponsive intermediate /high-risk NMIBC.
Affiliated with the best: Cedars-Sinai Excellence in Care
Tower Urology is a proud affiliate of Cedars-Sinai Medical Center, ranked #1 in California and #2 in the nation by U.S. News & World Report.
This partnership reflects our commitment to delivering thehighest standard of urologic care. Access to Cedars-Sinai’s world-class facilities and our exceptional, innovative, and state-of-the-art urological care make Tower Urology a care leader in California.
